Becton, Dickinson and Co Shows It's "Consistent" and "Reliable" in the Face of Headwinds

The fiscal fourth-quarter revenue at Becton, Dickinson (NYSE: BDX) isn't going to win any growth competitions, but the medical and life sciences conglomerate continues to cut costs, allowing its earnings to grow at a solid clip.

Metric

Q4 2017

Continue reading


Source: Fool.com